Article
Lipid metabolism reprogramming in endometrial cancer: biological functions and therapeutic implications
10 Sept 2024
Abstract excerpt
BACKGROUND: Endometrial cancer is one of the major gynecological cancers, with increasing incidence and mortality in the past decades. Emerging preclinical and clinical data have indicated its close association with obesity and dyslipidemia. Metabolism reprogramming has been considered as the hallmark of cancer, to satisfy the extensive need of nutrients and energy for survival and growth. Particularly, lipid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
